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ABSTRACT 
 
Macrophages are the host cells for Rhodococcus equi. Activation of FcγRI can 
induce phagocytosis, antigen presentation, cytokine production, antibody-dependent cell 
mediated cytotoxicity, reactive oxygen species (ROS) production, and induction of 
autophagy machinery in macrophages. Here we observe enhanced macrophage 
bactericidal activity against intracellular R. equi concurrent with superoxide production 
and induction of autophagy. Following ligation of IFN-γ, TLR4 and FcγRI receptors, 
murine bone marrow-derived macrophages, equine pulmonary-alveolar macrophages 
and monocyte-derived macrophages were tested for superoxide production, induction of 
autophagy and bacterial load through multispectral imaging flow cytometry, western blot 
and confocal microscopy. Results show that ligation of these receptors alone or in 
combination enhanced superoxide production and induction of LC3II. Importantly, 
however, FcγRI activation with a synthetic homodimeric peptide resulted in a sustained 
effect leading to a profound reduction in bacterial load as compared with other receptor 
agonists. These data are consistent with the notion that production of superoxide 
enhances autophagy resulting in reduction of bacterial load in infected macrophages.
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CHAPTER 1. GENERAL INTRODUCTION AND LITERATURE 
REVIEW 
 
Thesis Organization 
This thesis comprises five chapters. Chapter 1 is a literature review that 
familiarizes the reader with background information about innate and adaptive 
immunity, macrophages as host cells of intracellular pathogens, FcγRI in macrophages, 
production of superoxide, autophagy in macrophages and the pathogen Rhodococcus 
equi. In addition, reasons why the research presented was performed are presented. 
Chapter 2 describes FcγRI mediated intracellular reduction of Rhodococcus equi load in 
infected macrophages using a homo dimeric peptide specific for FcγRI. Chapter 3 
discusses the results of activation of FcγRI in the production of superoxide, induction of 
autophagy and reduction of bacterial load. Chapter 4 concludes this thesis and briefly 
highlights further investigations required to effectively activate macrophages in vivo to 
clear the pathogen using a homo dimeric peptide FCγRI binding strategy. References 
cited are listed at the end of the thesis. 
Literature Review 
Innate Immunity 
The mammalian immune system is comprised of innate and adaptive arms. The 
innate immune system, also known as non-specific immune system, is the first line of 
defense against pathogenic microorganisms (25). Innate immune cells include a group of 
specialized hemopoietic cells including: phagocytes (neutrophils, monocytes, 
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macrophages, and myeloid dendritic cells (DCs)); innate lymphocytes (natural killer 
cells, NKT cells, γ/δΤ cells, and plasmacytoid DCs, along with mast cells, basophils, 
eosinophils, and nuocytes (60). In addition, nonprofessional phagocytic cells such as 
epithelial cells, endothelial cells, and fibroblasts also contribute to innate immunity (70). 
Cells of innate immune system recognize pathogens with their conserved pattern-
recognition receptors (PRRs). Antigen presenting cells like DCs and macrophage 
recognize pathogen associated molecular patterns (PAMPs) with the help of PRRs 
(1,53). The PAMPs recognition by PRRs in antigen presenting cells leads to their 
activation and subsequent elicit of an adaptive immune response. There are various kinds 
of PRRs: TLRs, RIG-I–like receptors, Nod-like receptors (NLRs), and C-type lectin 
receptors (CLRs) (1,27,70). Collectively these cells and their respective 
ligands/receptors recognize and respond to invading viral, bacterial, fungal and parasitic 
invaders. 
Adaptive immunity 
The adaptive immune system, also known as the acquired immune response, is 
composed of highly specialized T and B-lymphocytes, which are involved in the process 
that eliminates pathogen or prevents/limits pathogen growth (25). In contrast to the 
pathogen recognition of the innate immune system, adaptive immune responses depend 
on receptors that are not encoded in the germ line but are generated de novo in each 
organism. The specific receptors are selected through a process of somatic 
recombination (gene rearrangement) of a large pool of gene segments and V(D)J 
recombination (25,1,4).  This mechanism involves a small number of genes to generate a 
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tremendous number of different antigen receptors, which are then expressed on each 
individual lymphocyte capable of recognizing components of potential pathogens. In 
addition to specificity, immunological memory is another principal feature of the 
adaptive immune system. It involves a tightly regulated interaction between antigen-
presenting cells and T and B-lymphocytes, which help in elimination of pathogens in the 
late phase of infection and generation of immunological memory (1, 4). After the first 
encounter with the pathogen, long-lived memory B cells and memory T cells are 
produced which are key in specific immunity. They have the capacity to get activated 
quickly and generate robust protective responses in case of re-exposure to same 
pathogen (4,40,8).  
Macrophage 
Macrophages are the immune cells which are involved in the primary response to 
pathogens, in the tissue homeostasis, coordination of the adaptive immune response, 
inflammation, resolution, and repair. (44). Macrophages originate as mononuclear 
phagocytes which represents a subgroup of leukocytes described as a population of bone 
marrow derived myeloid cells. (27,48). Mononuclear phagocytes are composed of 
monocytes, macrophages and dendritic cells. Macrophage precursors are released into 
the circulation as circulating peripheral-blood mononuclear cells (PBMCs) and they give 
rise to a variety of tissue-resident macrophages throughout the body. (48,16,7).  Tissue 
resident macrophage includes lung (alveolar macrophage), bone (osteoclasts), central 
nervous system (microglial cells), connective tissue (histiocytes), liver (kuffer cells) 
(46). Several macrophage subsets with distinct functions and physiological roles have 
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been described which arise in response to different innate or adaptive immune signals. 
Broadly, three population of macrophage have been proposed that can arise in response 
to cytokine stimuli from immune cells. Classically activated macrophages (M1 
macrophages) arise in response to interferon- (IFN) produced by T helper 1 (TH1) cells, 
CD8+ T cells or natural killer (NK) cells or tumor-necrosis factor (TNF), produced by 
antigen-presenting cells (APCs); Wound-healing or alternatively activated macrophages 
(M2 Macrophages) in response to interleukin-4 (IL-4), produced by TH2 cells or 
granulocytes; Regulatory macrophages generated in response to various stimuli, 
including immune complexes, prostaglandins; G-protein coupled receptor (GPCR) 
ligands, glucocorticoids, apoptotic cells or IL-10. Each of these three populations has a 
distinct physiology. Classically activated macrophages have microbicidal activity, 
whereas regulatory macrophages produce high levels of IL-10 to suppress immune 
responses and wound-healing macrophages involved in tissue repair. (46, 48).  
Macrophages are equipped with a broad range of receptors that make them 
efficient at recognition of pathogen, phagocytosis and induction of inflammatory 
cytokines.  Pathogen recognition is followed by surface changes, uptake, signaling, and 
altered gene expression, contributing to homeostasis, host defense, innate effector 
mechanisms, and the induction of acquired immunity (71,16).  Phagocytic surface 
receptors include non-opsonic receptors (e.g. C-type lectins and Scavenger Receptors) as 
well as opsonic receptors (e.g. complement receptor and Fc receptors). Toll-like 
receptors (TLRs) are pathogen-sensing receptors, some of which are expressed on the 
surface (e.g. TLR4), while others are vacuolar (e.g. TLR9). Sensing receptors are also 
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found in the cytoplasm, and these include the NOD-like receptors (NLRs), RIG-like 
receptors (RLRs), and DNA sensors (e.g. AIM2) (60,67). Macrophages are responsible 
for engulfing pathogens and killing them. However, some pathogens resist and subvert 
this process and continue to live inside the macrophage. In this way they also serve as a 
host for various intracellular pathogens like M. tuberculosis, R. equi, Leishmania and 
many viruses (27).  
CD64 (FCγRI) in Macrophage 
Fc receptors are the proteins found on the surface of macrophage and other 
phagocytes, which play a central role in immunity. On the surface of the macrophage, 
several Fc receptors are expressed which bind to the different classes of 
immunoglobulins  (51). The family of Fc receptors binding to IgG (FcγR) belongs to the 
immunoglobulin superfamily and plays a crucial role in phagocytosis of pathogens (5). 
The FcγR family in mice and humans is composed of one high-affinity activating 
receptor, FcγRI (CD64); FcRs are with low to medium affinity for the antibody Fc 
fragment and inhibitory FcRs. In humans three different classes of FcγR are known and 
four in mice. FcγRI is the high affinity receptor that binds monomeric IgG2a in mice and 
IgG1 and IgG3 in humans (51). IgG are the most abundant and important isotype in 
serum which form IC (immune complexes) and are involved in the interaction with 
FcγRI expressed on the surface of macrophages. Activating FcγRI can induce 
phagocytosis, antigen presentation, the production of reactive oxygen species (ROS) and 
cytokines, and antibody-dependent cellular-mediated cytotoxicity (ADCC). FcγRI is 
expressed on most myeloid cells including monocytes, macrophages, and dendritic cells.  
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Moreover, granulocytes express FcγRI upon activation, and FcγRIIA can also be 
expressed on platelets and B cells. IFNγ is a potent stimulator of FcγRI expression (2, 
51).  In mice, FcγRI has similar high-affinity binding properties as its human ortholog. 
Although the extracellular structures are comparable, considerable differences in 
intracellular domains exist between mice and humans. Human FcγRIIA contains ITAM 
in its intracellular domain, which is not present in mouse FcγIII. Importantly, murine Fcγ 
RI and FcγRIV preferentially bind mIgG2a, and in contrast to FcγRI, FcγRIV binds this 
isotype with moderate affinity (51).  Mouse models emphasized the role of various FcRs 
in normal immunity and in various disease models and Ab therapy. Moreover, 
identification and use of an Fc-mimic cyclic peptide family that works as IgG has been 
reported. With a strict specificity for FcγRI, it has been shown to be able to mimic IgG-
Fc interaction and FcγR co-localization, which could be used for treatment of different 
disease conditions (3). In another study, antibody mediated host cell protection against 
intracellular pathogens which evade lysosomal fusion has been shown. Using specific 
antibodies, FcR are engaged and the intracellular pathogenic bacterium is targeted into 
the lysosomal compartment. The pathogen targeting to the lysosomal compartment is 
dependent on FcR signaling and is independent of FcR mediated phagocytosis (28).  
Superoxide Production in Macrophage 
Reactive oxygen species (ROS) are essential components of the innate immune 
response against intracellular bacteria (36). Phagocytic leukocytes like macrophages 
generate reactive oxygen species in response to appropriate external stimuli, such as 
FcγRI and TLR signaling. Cross-linking of FcγRI on macrophage triggers production of 
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superoxide anion (O2- ). Superoxide is produced continuously over a long period at the 
subsaturating concentration of FcγRI ligands (58). FcγRI activation on human monocytic 
cells results in a transient activation of NADPH oxidase (59).  Mitochondria and 
NADPH oxidase (NOX) are actively involved in production of reactive oxygen species 
(ROS) across the membrane of phagocytes.  It has been shown by various sources that 
mitochondria are the main source for regulation of autophagy by ROS whereas NADPH 
oxidase is involved in the trigger of bacterial autophagy (23,24). NADPH oxidase, a 
multi-protein complex, exists in the dissociated state in inactive cells and after 
stimulation it assembles into the functional oxidase complex and then generates 
superoxide anions (64, 66). In phagocytes, NOX enzymes are assembled on the 
phagosomal membrane and produce superoxide by transferring electrons from cytosolic 
NADPH to oxygen in the phagosomal lumen. The oxidase complex consists of a 
membrane bound catalytic subunit gp91phox (NOX2) and regulatory cytosolic subunits 
p22phox, p47phox, p40phox, p67phox and the small GTPase RAC (62). The assembly 
of the cytosolic subunits with gp91 phox to form an active complex regulates the activity 
of gp91phox.  Studies have shown that superoxide production via phagocytosis is 
triggered by p40phox and binds to phosphatidylinositol-3-phosphate, a phosphoinositide 
found in the membranes of phagosomes. NADPH oxidase activation is the crucial 
downstream event of phagocytosis and plays a key role in clearance of the intracellular 
pathogens (23, 72). 
Autophagy in Macrophages 
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Autophagy is a fundamental cellular homeostatic mechanism in which cytoplasmic 
material, damaged organelles, protein aggregates, or invading pathogens delivered to 
lysosomes for degradation involve formation of double-membrane vesicles, called 
autophagosomes which sequester cytoplasm (23, 39,33).  Autophagy is emerging as an 
important innate defense mechanism against pathogenic infection, including bacteria, 
virus, and parasites. When autophagy results in the killing of intracellular pathogens it is 
referred to as xenophagy (47, 39). In addition to its role in pathogen degradation, it has 
also been shown to activate adaptive immune system. It also plays an important role in 
the destruction of intracellular pathogens as well as antigen processing and presentation 
(39,38).   
Microtubule-associated protein chain 3 (LC3) is widely considered as an 
autophagy marker protein. Conversion of LC3 I to LC3 II is positively correlated with 
induction of autophagy and formation of autophagy vacuoles. Similarly, Beclin1 or 
autophagy related gene (Atg 6) plays an important role in initiation of autophagy in 
forming autophagy vacuoles (20). The autophagy system can target bacteria in 
phagosomes, stimulating phagosome maturation and preventing pathogen escape into the 
cytosol. In response to specific signaling events, such as FcγR, TLR and IFNγ signaling, 
the NOX2 NADPH oxidase is assembled on the formation of phagosomal membrane 
and generates superoxide via transfer of electrons from cytosolic NADPH to oxygen in 
the lumen of the phagosome. Recent research studies have provided evidence that 
NOX2-generated reactive oxygen species (ROS) are necessary to target LC3 to 
phagosomes. FcγR-mediated phagocytosis alone can induce LC3 recruitment to 
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phagosomes, revealing a coupling of superoxide production with induction of autophagy 
(23,65). Similarly, it has been shown showed that cytokines also control autophagy, such 
as T helper type 1 (Th1) cytokines like tumor necrosis factor (TNF)-α and interferon 
(IFN)-γ; inhibited by the Th2 cytokines - interleukin (IL)-4 and IL-13 and the anti-
inflammatory cytokine IL-10 via the PI-3-kinase pathway (50, 56). Recent studies have 
demonstrated that specific induction of autophagy can overcome inhibition of 
phagosomal maturation and lead to suppression of intracellular M. tuberculosis load, 
indicating promising clinical outcomes by enhancement of innate mechanisms of 
xenophagy (50). Following autophagy induction, Beclin-1 and its binding partner class 
III phosphoinositide 3-kinase (PI3K) are necessary for initiation of autophagosome 
formation (39), inferred by detection of microtubule-associated protein light chain 3 
(LC3), which exists as a cytosolic protein (LC3-I) until induction of autophagy 
whereupon a lipidated membrane bound protein is formed (LC3-II) (20).  Similarly, 
recent research studies have shown Rubicon, a RUN domain protein as Beclin-1 
interacting and cysteine-rich containing autophagy protein, as a positive regulator of 
NADPH oxidase.  After microbial infection or ligation of TLR2, rubicon interacts with 
the p22phox subunit of the NADPH oxidase complex, accelerating its phagosomal 
trafficking to induce a burst of reactive oxygen species (ROS) and inflammatory 
cytokines. Rubicon's actions in autophagy and phagocytosis are shown to be functionally 
and genetically separable and outcome depends on the environmental stimuli (75,76).  
Rhodococcus equi and immunity related with it 
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Rhodococcus equi is a Gram-positive, obligate aerobic, facultative intracellular 
coccobacillus capable of replicating in macrophages, including alveolar macrophages 
(11,21,49).  It is closely related phylogenetically to Mycobacterium tuberculosis (45) 
and it causes severe pyogranulomatous pneumonia of disease in 6 weeks - 6 months old 
foals (61). It is a common causative agent of bacterial pneumonia in foals and 
immunocompromised adults. In addition, it has been shown to be an important zoonotic 
pathogen that causes tuberculosis-like symptoms in AIDS patients (61, 32). R. equi has 
evolved a mechanism to escape bactericidal activity in macrophages and instead it 
multiplies and finally kills macrophages by necrosis (42). Phagosomes containing 
virulent R. equi do not progress into endocytic organelles that fuse with lysosomes and 
thereby fail to acidify because of a lack of acquisition of the proton-pumping vacuolar 
ATPase (12). Replication and virulence of R. equi in host macrophages depends on the 
presence of unique and R. equi-specific family proteins, virulence-associated protein 
family (VAP family). There are six full-length VAP genes (VAP A, C, D, E, G, H) and 
3-truncated VAP pseudo genes (VAP F, I and X). Among them, the VAP A plasmid that 
encodes virulent, temperature inducible and surface expressed lipoprotein, is shown to 
be critical for virulence of R equi. VAP A is critical for intracellular growth in 
macrophages and induction of disease in foals. (69,17,12,54). 
Innate Immunity 
Typically, foals are susceptible to R. equi pneumonia 6 weeks after birth to less 
than 6 month of age. Inhalation is the common route of infection in foals (22).  After 
introduction into lungs, R. equi is engulfed by alveolar macrophages through a process 
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of receptor-mediated phagocytosis, which can be mediated by complement receptor 
(CR3 or Mac-1), macrophage mannose receptor, and TLR 2 (15). In addition, R. equi 
may use the mannose receptor for entry into the macrophage, which may recognize the 
lipoarabinomannan (LAM), one of the components of outer surface of bacteria. It may 
be either directly or through mannose binding protein or surfactant molecules attaching 
to LAM. (15,18). Once taken up by resident macrophages, virulent R. equi is able to 
modify the phagocytic vacuole to prevent acidification and subsequent fusion with 
lysosomes (12). The bacteria then alter its gene expression system to survive in the 
hostile environment. It increases its ability to uptake essential nutrients like iron to resist 
the reactive oxygen intermediates from the host (63). The macrophage dies by necrosis 
due to rapid growth of bacteria (42). R. equi opsonization with it’s specific antibody may 
promote it to be taken into macrophage via the Fc receptor and subsequent fusion of R. 
equi containing phagosome  with lysosome and may lead to killing (10).  Activating 
murine macrophages with IFNγ promotes the production of reactive oxygen and nitrogen 
intermediates. These two radicals alone can’t kill but when they combine to form 
peroxynitrite killing is achieved (9).  The other cytokine TNF-α might play synergistic 
role with IFNγ to clear the pathogen (31).  The early host defense is mediated by 
neutrophils, which clear the pathogen well when it is opsonized with specific antibody. It 
has been shown that macrophages from foal can’t clear the pathogen well whereas 
neutrophils from both foals and adult can clear it (43).   
Acquired Immunity 
Cellular Immunity 
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In mice, CD4+ T cells mediate the protective immune response against R. equi, 
however, the role of CD8+ T cell is not clear (26,17). IFNγ enhances the clearance of R. 
equi whereas biased production of IL-4 (Th2-biased) increases the risk of disease (26). 
Both CD4+ and CD8+ T cells are involved in the clearance of the organism in the horse. 
(30). Foals that develop R. equi pneumonia have comparable CD4+ and CD8+ T cell 
distributions in peripheral blood with healthy foals (14).  Moreover, T lymphocytes and 
plasma cells are virtually absent in lung tissues in the first week of life, and bronchus-
associated lymphoid tissue (BALT) is only observed by 12 wk. of age (14). In addition, 
the availability of leukocytes in bronchoalveolar lavage fluid in foals less than 3 wk. of 
age is one-half the value for adult horses. The percentage of CD4+ T cells increases 
markedly in the first 3 wk. of life, reaching values comparable with adult horses by 8 
wk. Therefore, the pulmonary leukocyte population is quite limited during the first 
several weeks of life, and it is unlikely that these cells would control substantial airway 
infection during this period. Adult horses and greater than 6-wk-old foals develop CTLs 
which efficiently kill R. equi-infected cells; however, this is not observed with CTLs 
from foals younger than 3 weeks of age (57).  CD8+ T cells recognize and kill R. equi 
infected macrophages in a major histocompatibility complex class I (MHC class I) 
unrestricted fashion in adult horses (57). Foal monocyte-derived macrophages express 
lower levels of CD1 than adult horse cells, and R. equi infection trigger lower expression 
of CD1b on equine monocyte-derived macrophages. This may contribute to longer 
disease duration in the foal, which already has reduced CD1 expression (55).  
Humoral Immunity 
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Antibodies play a crucial role as opsonins for efficient phagocytosis. In the foal, 
humoral protection would be useful during the initial exposure to the pathogen, before R. 
equi reaches the intracellular environment. Therefore, in the neonate, the passive transfer 
of immunoglobulin through colostrum or plasma transfusion could be helpful in 
providing the initial protection in the airways until its own cellular and humoral 
immunity are developed (6).  Active immunization of mares, and the subsequent passive 
transfer of immunity to foals via colostrum ingestion, does not appear to consistently 
prevent foals from developing R. equi pneumonia. Studies have reported no significant 
reduction in R. equi pneumonia with the use of vaccines that contained killed or 
inactivated R. equi strains (14,18). There is also disparity in prevention of disease in 
foals using the R. equi specific transfusion of hyperimmmune plasma. In studies by 
Caston et al., 2006, in equine neonates infected experimentally with R. equi, intravenous 
plasma transfusion containing specific antibodies against R. equi or VapA administered 
before infectious challenge, aided significantly in the recovery of disease compared with 
placebo.  
In naturally infected foals and herd studies, intravenous administration of 
hyperimmmune plasma showed a decrease in the incidence of pneumonia, a reduction in 
the risk of developing disease, or no significant effect, which suggests the participation 
of other risk factors (e.g., pathogen exposure or competence of different arms of the 
immune system) in the development of disease in natural conditions. It is possible that R. 
equi specific antibodies and other non-specific immunomodulators present in plasma 
may synergistically enhance bacterial removal and killing (18). The mechanism of 
	   14	  
protection with hyperimmmune plasma has not been fully described.  The viability of 
intracellular bacteria may be affected by the opsonization, but results suggest the need 
for additional activation of macrophages to elicit effective bacterial killing (18,49). 
Conclusions 
R. equi infection in foals is a serious and complex problem. R. equi evolved 
resistance to escape mechanisms of bacterial killing. Naive foals are exposed to high 
numbers of virulent bacteria on farms endemic with R. equi. However, most foals do not 
develop disease, suggesting individual risk factors. Research findings suggest that 
susceptibility to R. equi infection and disease in the foal is not because of their inability 
to produce a Th1-type immune response, although this type of response requires time 
and effective signaling interaction between antigen-presenting cells and lymphocytes. 
The effect of colostrum or hyperimmmune plasma derived R. equi specific antibodies in 
the neutralization and opsonization of the bacterium before it reaches the intracellular 
space is not clear. Passive transfer of immunoglobulin through intravenous plasma 
transfusion helps but does not prevent disease completely. Efforts have increased in 
recent years, with the ultimate aim of developing immunoprophylactic approaches (such 
as vaccines and hyperimmmune plasma) or other control strategies to prevent disease. A 
number of immune factors predispose some foals to R. equi infection, such as deficient 
serum opsonic activity, limited TLR signaling and CD86 expression by dendritic cells, 
reduced MHC class II and CD1 expression on APC, and deficient IFN-γ signaling by 
CD4+ and CD8+ T cells. All these factors play a role in limiting innate immune 
mechanisms and subsequent development of an effective acquired cell-mediated immune 
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response to R. equi during the early stages of a foal’s life. It may be that in some foals, 
the developing TH1 response may not be adequate to combat a concentrated aerosol 
challenge. An effective immune response to R. equi infection consists of a mixed 
Th1/Th2 cell-mediated response. The potential vaccines/adjuvants to stimulate the 
limited innate immune response of foals that may be tried include FCγRI agonists, TLR 
agonists, MHC-II and CD1 activators to improve the presentation of protein, lipid and 
lipoarabinomannan antigens, characteristic of R. equi to T cells.  
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CHAPTER 2. FCΥRI-MEDIATED INTRACELLULAR REDUCITON OF 
RHODOCOCCUS EQUI LOAD IN INFECTED MACROPHAGES 
 
Abstract 
Macrophages are the host cells for Rhodococcus equi. Activation of macrophage 
FcγRI can induce phagocytosis, antigen presentation, cytokine production, antibody-
dependent cell mediated cytotoxicity, reactive oxygen species (ROS) production, and 
ROS-dependent induction of autophagy machinery. Here we demonstrate enhanced 
macrophage bactericidal activity against intracellular R. equi. Murine bone marrow-
derived macrophages were tested for the reduction of bacterial load following ligation of 
FcγRI.  Similarly, bacterial load in infected macrophages was analyzed with 
multispectral imaging flow cytometry and confocal microscopy. Results show that 
stimulation of FcγRI achieves significant reduction of the bacterial load in infected 
macrophages. The data are consistent with the notion that production of superoxide 
enhances autophagy resulting in reduction of bacterial load in infected macrophages.  
Introduction 
Rhodococcus equi is a facultative intracellular bacterium that can cause 
bronchopneumonia in foals.  It is the most serious cause of pneumonia in foals 1-5 
month of age; but adult horses, unless they are immunocompromised, are not 
susceptible. R. equi has also emerged as an opportunistic pathogen in immunosuppressed 
humans, especially those infected with HIV.  R. equi is a gram-positive, facultative 
intracellular pathogen that is nearly ubiquitous in soil. Only certain types (Vap A, B, C) 
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are pathogenic. The actinobacteria R. equi and human pathogen M. tuberculosis are 
phylogenetically related. A variety of antimicrobials are active against R. equi when 
evaluated in vitro. However, many of these antimicrobials are ineffective in vivo. R. equi 
has been reported to develop progressive antimicrobial resistance causing difficulty in 
treating foals. The protection of hyper-immune plasma has not been consistent to save 
foals from high morbidity and mortality against this disease.   
FcγRI is the high affinity IgG binding/activating receptor on the surface of 
macrophages and monocytes.  After binding IgG, FcγRI interacts with an accessory 
chain known as the common γ chain (γ-common chain), which possesses an ITAM motif 
that is necessary for triggering cellular activation. Mouse models emphasized the role of 
various FcRs in normal immunity and in various disease models and antibody therapy. 
Moreover, identification and use of a cyclic peptide that works as IgG has been reported. 
With a strict specificity for FcγRI, it has been shown to be able to mimic IgG-Fc 
interaction and FcγR co-localization, which could be used for treatment of different 
disease conditions (3). In another study, antibody-mediated host cell protection against 
intracellular pathogens, which evade lysosomal fusion, has been shown using specific 
antibodies whereby FcR are engaged and the intracellular pathogenic bacterium is 
targeted into the lysosomal compartment. Targeting to the lysosomal compartment is 
dependent on FcR signaling and is independent of FcR mediated phagocytosis (26,27). 
Materials and Methods 
Cells and cell culture 
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Bone marrow cells were harvested from femurs and tibias of C3HeB/FeJ mice.  Briefly, 
bone marrow was flushed out from the long bones of the limbs with complete cell 
culture medium (CTCM), with DMEM (Dulbecco’s modification of eagle’s medium) 
and supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin, 
and 100 µg/ml streptomycin, 0.05 µM 2-mercaptoethanol, 4.5 g/L Glucose and 25 mM 
HEPES. Cells were centrifuged at 250 g for 15 minutes at 40C. The cell pellet was 
resuspended in bone marrow medium (30% L-cell conditioned medium, 20% fetal 
bovine serum (FBS), 50% DMEM, 2 mM L-glutamine, and 100 U penicillin per ml, 100 
µg of streptomycin per ml and 1 mM sodium pyruvate). (20-25) X106 cells was seeded 
into 15 mm petriplate and incubated at 370C in 5% CO2. On day 2 of culture, non-
adherent cells were gently removed and fresh Bone marrow medium was added. At day 
6, the adherent cell population was collected and after washing with PBS, trypan blue 
exclusion was used to count live cells, which were resuspended in complete tissue 
culture medium. 
Bacterial Preparation 
R. equi stock from -800 C was thawed and streaked onto an LB agar plate and 
was grown for 30 hours in 370 C.  Preparation of inoculum R. equi, strain T194, was 
provided as a clinical isolate from a pneumonic foal by Dr. Ronald Griffith, Iowa State 
University. A single colony was seeded to 20 mL of brain, heart infusion (BHI) media 
for 15 hours in a shaking incubator at 200 rpm in 370C to an O.D. of 0.25, which 
corresponds to 108 bacteria per ml. Bacteria were washed in sterile PBS and resuspended 
in the brain hearth infusion (BHI) broth spinning at 10,000 rpm for 5 mins. 
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Confocal Microscopy 
BMDMs (0.5 million) were seeded in 24 well plates with tissue coverslips and 
infected with R. equi at MOI 3 for different time points. Later the cells were fixed, 
permeabilized and incubated with rabbit polyclonal R. equi antibodies (1:3000) for 1 
hour as primary antibodies. The coverslips were incubated with goat anti-rabbit Alexa 
488 (1:3000) as secondary antibodies for 30 minutes. Later the coverslips were mounted 
with prolong Gold antifade reagent with DAPI upon the slide and visualized under 
Olympus Confocal microscope. 
Quantification of intracellular bacterial replication and reduction in load 
To investigate intracellular bacterial quantification and reduction in load, 2 x 106 
BMDMs were plated in flow tubes with CTCM medium. Cells were infected with MOI 
3 Rhodococcus equi strain T194. After 2 hours the cells were washed with 1X PBS at 
250 g for 10 min at 40C to remove extracellular bacteria and added fresh CTCM 
containing 50µg/ml gentamicin.  The macrophages were then activated with homo-
dimeric peptide (as described in Bonetto et. al, 2009, fig 3.1) consisting of 6 µM/ml.  At 
different time points (3hr, 6hr, 12hr, 24hr, 48hr, 72hr, 96hr) post-activation the cells 
were analyzed for reduction in the bacterial load. For analysis, 0.5 million cells from the 
original flow tube were taken and transferred into clear-view snap cap micro centrifuge 
tubes. The cells were washed by adding 1 ml of cold wash buffer (2% heat inactivated 
FBS, 0.1% sodium azide in 1XPBS) at 250 g for 10 min at 4 degree C.  The supernatant 
was discarded and residual buffer removed by tapping the inverted micro centrifuge tube 
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on paper towel. The cell pellet resuspended by gently raking the micro centrifuge tube 
across a test tube rack.  The cells were fixed by adding 100 µl 4% paraformaldehyde in 
PBS for 15 min at room temperature (RT). The cells were washed by adding 1 ml of 
wash buffer and centrifuged at 250 g for 10 min at 4 degree C. Following fixation, the 
cells were permeabilized with 0.1% Triton-X 100 for 4 min at room temperature and 
washed with wash buffer at 250 g for 10 min at 40C. Blocking was done using blocking 
buffer (10% goat serum, 0.4% bovine serum albumin in 1X PBS). Primary and 
secondary antibodies were diluted 1:3000 in blocking buffer.  To stain intracellular 
bacteria, cells were incubated with 200µl of primary antibody (rabbit polyclonal R. equi 
antibody as described in Ramos et. al, 2011) for 30 min at room temperature and washed 
with the wash buffer. The cells were then stained with secondary antibody (Alexa Fluor 
488 goat anti-rabbit IgG, Invitrogen) for 30 min at room temperature and washed with 
wash buffer at 250 g for 10 min at 40C. Cells then resuspended in 50µl of PBS 
containing 1% PFA and stored in the dark at 40C until acquisition in Amnis-
ImageStreamx and Image analysis was performed using Amnis-IDEAS version 5.0 
(Amnis Corporation, Seattle, WA). 
Overview of Sample Acquisition and Image Analysis 
 
Initially, the appropriate numbers of events to be acquired were determined along 
with the use of different types of fluorescent dyes.  Similarly, cell classification criteria 
were determined to eliminate the unwanted events. Sample collecting channels were 
selected. A different single color sample was acquired for each fluorophore in the 
experiment to develop a compensation matrix. Test samples were acquired and saved for 
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the image analysis. For image analysis, the IDEAS program was launched and 
internalization wizard selected and the test sample was run. The compensation matrix is 
developed using single color controls in the experiment. Appropriate channels were 
selected for the respective populations. A single cell population and best-focused cells 
were selected for the data analysis. Proper gating strategy was applied and determined to 
better characterize the internalization of R. equi. The IDEAS mask function, spot, peak 
and intensity data analysis options were used define the spot count in the cell. A 
statistics report was generated. Image analysis was performed using IDEAS software. 
For details see please see Appendix A and B. 
 
Results 
 
 
 
Figure 1. Structure of parallel homodimeric peptide. Peptide is depicted in single-letter 
amino acid code as described in Bonetto et al., 2009.  
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Figure 2. Internalization of R. equi in the bone marrow derived macrophages. The green 
are (AF488) R.equi and blue is DAPI nuclear stain. Monolayers of BMDM cells were 
infected with R. equi T194 and fixed at different time points post infection and stained to 
visualize the spatial relationship of the bacteria with the host cell. The images show the 
subsequent increase of bacterial load in the infected macrophages over the time. Bacteria 
were labeled with polyclonal R. equi as described in M&M. Scanning laser confocal 
microscopy was used to collect these images. 
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Figure 3. Schematic gating strategy applied to determine the internalization of R. equi. 
For details of gating strategy see Appendix A. 
 
 
 
Figure 3A. To gate cells in focus, the IDEAS feature Gradient RMS of the bright field 
image is plotted in a histogram. The gradient RMS feature measures the sharpness 
quality of an image by detecting changes of pixel values in the image. A higher gradient 
RMS values indicates a more focused image.  
 
 
 
 
Figure 3B. To analyze single cells only, it is important to get rid of multicellular events 
and debris. Single and multicellular aggregate events were separated using IDEAS 
features area and aspect ratio of bright field image. A gate was drawn to limit only the 
single cell events. 
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Figure 3C. To separate green fluorescent cells, a gate was drawn on the cells with high 
max pixel values and Intensity in the green fluorescence channel. The selected cells in 
the gate included the AF 488 positive cells. 
 
 
 
 
Figure 3D. The cells in the internalized gate from figure 1C was further characterized 
based on the number of spots.  
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Figure 4. Cell images of internalized R. equi. Representative images of BMDM cells 
that internalized R. equi. The channel 01 (Ch01) is the bright field image; Channel 02 
(Ch02) is AF488 and Last panel Ch1/Ch2 is the overlay of channel 1 and Channel 2 
combined. The image is of 40X magnification and Multi Spectral imaging flow 
cytometer was used to collect these images. 
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Figure 5. Effect of different concentration of homodimeric peptide in reducing the 
bacterial load in the infected macrophage with R. equi. BMDM cells were infected with 
R. equi and different concentration of peptide were added 2 hour post infection and 
sample was run in MIFC 96 hour post infection.  Final concentration of 6µM of peptide 
was effective in reducing the bacterial load significantly. Results represent means of 
samples in duplicates, and were confirmed by separate independent experiments. 
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Figure 6. Homodimeric peptides acts via FcγRI to reduce R. equi load (percent 
macrophages positive for bacteria) in the infected macrophages. BMDM cells were 
infected with R. equi and peptide concentration of 6µM was added 2 hrs post infection 
and sample from 72 hrs and 96 hrs post infection was run in MIFC. Percentage of 
bacterial internalization was calculated using IDEAS software. R. equi was significantly 
reduced in Peptide added macrophages as compared with the no peptide applied 
macrophages. (Student’s t test P values: ** P<0.01 and * P<0.05). 
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Figure 7. Effect of addition of Peptides on R. equi infected BMDM cells. Overlay of 
three different treatment groups (Pink- no peptide treated group; Green- Peptide treated 
group; Red- Non infected control). (A) Overlay of bacterial spot count and (B) overlay 
of spot intensity. Data is from 96-hour time point.   
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Figure 8. Comparison of three treatment groups using mean spot count. Untreated 
group, peptide used group and uninfected. The untreated group (no rx) shows the highest 
number of bacteria and treatment with peptide (pep) shows the reduction in bacterial 
load when compared with uninfected controls. Results represent means of samples in 
duplicates, and were confirmed by separate independent experiments.  
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CHAPTER 3. DISCUSSION 
Rhodococcus equi remains a great challenge to the health of young foals and 
immunocompromised adults. It is recognized as a major cause of pneumonia in foals 
(69). It remains a major concern for equine breeders worldwide (49). The incidence of R. 
equi pneumonia appears to be increasing possibly because of intensified management of 
equine breeding farms and climate change. This disease continues to be major challenge 
for clinicians and the equine industry in terms of epidemiological pattern and therapeutic 
control due to its complex host-pathogen interaction causing disease (69,49).  
It appears that innate, humoral and cell mediated immune responses all play a 
role in susceptibility to R. equi pneumonia. It has been shown that immunocompromised 
AIDS people are susceptible to R. equi. AIDS patients get suppression of cell-mediated 
immunity as a result of selective depletion of CD4+ T cells, which supports the role of 
cellular immunity for protection against R. equi (61,32).  Similarly, studies have shown 
an age-dependent increase in IFNγ production in foals. However, foals are shown to be 
able to produce IFNγ when activated with proper stimuli and mount Th1 response (26). 
In one study, a dose dependent correlation of Th1/Th2 responses has been demonstrated. 
Infection with low CFU of R. equi has shown to trigger a Th1 response whereas 
infection with higher CFU elicits a Th2 response (18). Similarly, antigen specific 
immunoglobulin is necessary in opsonization and phagocytosis of virulent R. equi by 
alveolar macrophage. Low circulating IgG titers in the foal may contribute to the 
susceptibility of R. equi pneumonia in foals (61,6,49). The use of hyperimmmune 
plasma to prevent R. equi infection is also not well described (10).  
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 R. equi is an intracellular coccobacillus that survives and replicates in 
macrophages, including alveolar macrophages (21). It interferes with phagosomal 
maturation following phagocytosis and suppresses acidification of the phagosome. 
Phagosomes containing virulent R. equi do not progress into an endocytic organelle that 
fuses with lysosomes. Intracellular replication leads to necrosis of the macrophage and a 
pyogranulomatous inflammatory response (42).  
The objective of the work here was to assess the effect of activation of FcγRI on 
production of superoxide, induction of autophagy and the reduction of intracellular R. 
equi load. Macrophages were infected with R. equi strain T194 and allowed to 
internalize. The infected macrophages were treated (or incubated) with IgG-Fc 
mimicking homodimeric peptide. With strict specificity for FCγRI, it has been shown to 
be able to mimic IgG-Fc interaction and FcγRI colocalization as described in Bonetto et 
al, 2009. Similarly studies have shown that engaging FcR with specific antibodies can 
target intracellular pathogen such as M. bovis and legionella pneumophila to the 
lysosome for degradation. The lysosomal targeting of phagosomes is dependent on FcR 
signaling but is independent of FcR mediated phagocytosis (28). In our experiment we 
used synthetic peptide to target FcγRI. The peptide in monomeric (soluble) form binds 
and blocks the receptor. In contrast, the homodimeric peptide activates macrophages 
accompanied by a burst of superoxide, which is necessary to kill intracellular pathogen 
like R. equi. To our knowledge, the targeting of an intracellular pathogen for lysosomal 
degradation using the IgG-Fc mimicking synthetic peptide strategy has not been 
previously demonstrated. In principle, this strategy could be used in combination or 
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alone with other agonists to control infection by an intracellular pathogen. Moreover, the 
efficacy and stability of the peptide in vivo needs to be tested. The result described here 
is post infection when R. equi is already inside the macrophage and peptide is added to 
the infected macrophage afterwards. In contrast, in the experiment by Joller et. al., 
macrophages were activated before the Legionella infection. Our results extend the work 
by these investigators highlighting the role of Fc signaling in the control of intracellular 
pathogens. In addition, this work suggests further that infected macrophages can be 
activated and can reduce the burden of an intracellular pathogen. The exact mechanism 
behind the reduction of the pathogen load needs to be elucidated. Intracellular replication 
of R. equi starts between 6 and 12 hours of culture and reaches at peak level at 48 hour 
of infection (21). In our study, up until 72-hour post infection there was no difference in 
bacterial load as compared with control. However, at 96-hour post infection there was a 
significant reduction in the intracellular bacterial load. Importantly, FcγRI activation 
with a synthetic homodimeric peptide resulted in a sustained effect leading to a profound 
reduction in bacterial load as compared with other receptor agonists.  
There have been studies regarding control of intracellular R. equi in macrophage 
using opsonization with R. equi specific antibody, but the results are not consistent and 
have shown only to be active against bacteria in the extracellular environment (10). 
Similarly, cytokine induced macrophage killing has also been shown, particularly with 
IFNγ and TNF-α which may be important for in vivo killing as well. Studies have 
demonstrated that by blocking IFNγ activity, mice fail to clear pulmonary R. equi 
infection. Moreover, the exposure of R. equi infected macrophage to IFNγ enhances 
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microbicidal activity with production of reactive oxygen and nitrogen intermediates (9). 
In our study, we used R.equi specific polyclonal antibody to measure the bacterial 
internalization and sensitivity by measure of fluorescence as well as to minimize the 
inaccuracy of bacterial counts due to clumping with the CFU method. However, it may 
be of limited use for in vivo studies. Previously, we had bio-transformed R.equi with 
GFP and RFP but fluorescence signals from them were not sensitive enough for bacterial 
quantification.  
In the present study, to detect and quantify internalized R. equi, we designed a 
high throughput quantitative experimental protocol that can detect bacteria as well as 
other internal markers associated with the bacteria. Until now, different independent 
techniques such as microscopy, flow cytometry, luciferase activity measurement have 
been the methods used to study the phagocytosis, internalization and quantification of R. 
equi. The techniques such as flow cytometry and luciferase activity measurement 
generate good statistical data but it is not able to accurately quantify internalization and 
progression into the phagosome. Similarly, microscopy generates images with better 
resolution but it is time consuming and involves small sample sizes. Overcoming the 
drawbacks of the independent techniques, multi-spectral imaging flow cytometry 
(MIFC) is a new technology that uses aspects of both microscopy and flow cytometry to 
perform multi-color spectral fluorescence and bright field imaging simultaneously 
through a laminar core. This helps to better analyze different intracellular fluorescent 
signal intensities and generate data at high speed. In contrast to the labor-intensive 
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counting of CFU, the use of MIFC requires no additional time for growth of the 
colonies.  
The fact that intracellular reduction of R.equi load in infected macrophage-using 
a peptide strategy was effective, this observation suggests an important way to treat 
R.equi pneumonia in foals. If sufficient amount of macrophage activating agonists such 
as homodimeric peptide can be delivered through inhalation, enhanced intracellular 
bacterial killing may be achieved. Moreover, the efficacy of this method needs to be 
tested by in vivo experiments. 
In the experiment we performed we were not able to demonstrate the pathway of 
internalization of R.equi in in macrophage. If the outcome of the efficacy of the homo 
dimeric peptide depends on the pathway of internalization, further experiments need to 
be performed. In addition, we were not able to use randomly generated peptide as a 
control along with the monomeric peptide of the same sequence, which could be used as 
a control. The data obtained in the present study provide new insights into the 
pathogenesis of and immunity against R. equi infection that require further investigation.  	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CHAPTER 4. GENERAL CONCLUSIONS AND FUTURE WORK 
 
General Conclusions 
Rhodococcus equi is an intracellular pathogen that has the capacity to survive 
and replicate within the alveolar macrophage following inhalation. It causes pneumonia 
in young horses and immunocompromised humans.  It replicates inside a specialized 
macrophage compartment, the R. equi containing vacuole (RCV) and arrests further 
phagosome maturation to fuse with lysosomes.  The bacteria then replicate inside the 
vacuole and the host cell eventually dies by necrosis.  The objective of this thesis was to 
explore a new therapeutic approach that can be used to treat rhodococcal pneumonia in 
foals. Despite advances in our understanding of the organism and its ecology, there are 
still important gaps in our understanding of the nature of disease due to R. equi and the 
nature of immunity in the foal. Why some foals are affected by these infections and 
others are not and why immunocompromised adults gets infection and adults do not 
remain unclear. At this point, we have little understanding of the role of immunogenetic 
factors predisposing foals to the disease. The discovery of specific innate host factors 
related to disease risk may help to clarify the pathogenesis and complex epidemiology of 
this disease. Because of the lack of therapeutic alternatives and rising concerns regarding 
antimicrobial resistance, there is a great need to develop alternative means for prevention 
and treatment of the disease. Finally, an effective therapeutic means remains elusive 
because of the complexity of the immune response to R. equi and the challenges posed 
by limitations of some elements of the immune response of young foals.  
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Overall my work demonstrated FcγRI activation with a synthetic homodimeric 
peptide results in a sustained effect leading to a profound reduction in bacterial load in 
the infected macrophages. Further in vivo testing of the peptide is needed to understand 
its efficacy for therapeutic use. This approach has also suggested alternatives to FcγRI 
activation that could be tested including approaches using multiple antigenic peptides 
(MAP).  
Future Works 
Given the reduction of bacterial load in the infected murine macrophage with the 
use of a homodimeric that specifically binds FCγRI peptide, it would be important to 
determine if the same is true for equine macrophages as well. In addition, further works 
regarding the mechanism of the bacterial killing and cellular signaling events associated 
with it need to be elucidated. Some of our preliminary works on ligation of FCγRI on 
murine bone marrow derived macrophages showed induction of Superoxide. In contrast, 
blocking with monomeric FcγRI peptides resulted in depressed superoxide production 
compared to controls. Further, we have observed differences in terms of superoxide 
production in foal and adult macrophages after ligation with the homodimeric peptide. 
This could result in differences of microbicidal activity between adult and foal 
monocyte-derived macrophages (MDMs) from blood and pulmonary-alveolar 
macrophages (PAMs) from bronchoalveolar lavage fluid (BALF). In the future it will be 
important to perform similar experiments to confirm the differences in the superoxide 
production and correlation with the reduction of bacterial load.  
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  Within the past decade, autophagy of foreign microorganisms (xenophagy) has 
become increasingly recognized as an important innate defense mechanism, particularly 
with respect to intracellular bacterial pathogens (23,24). Recent studies have 
demonstrated that specific induction of autophagy can overcome inhibition of 
phagosomal maturation and lead to suppression of intracellular M. tuberculosis load, 
indicating promising clinical outcomes by enhancement of innate mechanisms of 
xenophagy (50). In the line of xenophagy, in another set of studies, we infected bone 
marrow derived macrophages with R. equi and ligated with the peptide as well. Our 
preliminary data suggest the induction of cellular autophagy machinery in macrophages 
after FcγRI ligation with the peptide as well as infection with R.equi. Further studies are 
needed to describe these mechanisms. Finally, understanding-signaling pathways 
involved in the regulation of autophagy will be important in developing new strategies to 
abrogate infection with R.equi. 
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APPENDIX A 
SAMPLE ACQUISITION ON THE IMAGESTREAMX 
1. Power up ImageStreamX and launch INSPIRE. 
2. Initialize Fluidics. At the end of this script SpeedBeads should be running. 
3. In the file menu, choose Load Default Template. 
4. In the Image Gallery view menu, select ALL and Press Run Setup to start 
imaging the beads. 
5. Adjust Core Tracking to center images laterally (if necessary). 
6. Select the Brightfield (BF) channel and click Set Intensity. 
7. Wait until the Flow Speed CV is consistently less than 0.2%. 
8. Calibrate the instrument daily. In the ASSIST tab, click Start All to run 
calibrations and tests and verify that all have passed. 
9. Press Flush Lock and Load (FLL) to load the first sample. Load the brightest 
sample in the experiment that fluoresces with each fluorochrome used. It's 
critical that you run this sample first to establish the instrument settings and then 
DO NOT change them for the entire experiment. 
10. Turn on each laser used in the experiment and set the Laser Power so each 
fluorochrome has max pixel values between 100 and 4000 counts, as measured in 
the scatter plots. 
11. Set Cell Classification criteria, to eliminate collection of unwanted objects. For 
collecting data from only the cells, select the Area Lower Limit in BF channel to 
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50 µm. Objects with area less than 50 µm will be considered debris and will not 
be acquired. Select channels to be collected. 
12. Enter the File Name, Destination Folder, set Sequence # to 1 and the Number of 
Events to acquire. 
13. Click Run Acquire to collect and save the first experiment data file. 
14. Click FLL and run the next experimental sample. Repeat until all experimental 
samples have been collected. 
15. Click Comp Settings (turns off brightfield and scatter laser and enables collection 
of all channels) and collect 500 positive cells from each single stained sample for 
each fluorophore in the experiment to develop a compensation matrix. 	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APPENDIX B 
 
IMAGE ANALYSIS 
1. Launch IDEAS and double-click on the Internalization wizard and load one of 
the test sample .rif files. 
2. Create a compensation matrix by clicking on 'New Matrix' in step 2. The 
compensation wizard is launched. Add files for the single color controls in the 
experiment. Click next through the wizard following directions until the 
compensation matrix file is saved and loaded into the box in step 2 of the 
Internalization wizard. 
3. Click Next and follow directions until a .daf file is generated. 
4. Set image display properties by selecting the image channels used during 
acquisition. Click on Ch 2 (AF 488) (BF and SSC are default selected). 
5. Select the image channel for making the cell boundary (CH01) and the channel in 
which bacteria were collected (CH02). 
6. A scatter plot of Brightfield Area versus Brightfield Aspect Ratio of all of the 
cells is generated. Define the single cell population by clicking on individual dots 
and gating around singlets. Single cells have an aspect ratio of around 1 and 
doublets around 0.5. 
7. A histogram of the Brightfield Gradient Root Mean Square (RMS) of the 
brightfield image is generated and the population view in the image gallery is set 
to selected bin. Click on the bins to determine where cells in best focus begin and 
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draw a line region to gate focused cells. The higher the Gradient RMS, the better 
focused. Skip the next step unless there are other stains you want to gate on. 
8. A new scatter plot of Intensity of Channel 2 on the x-axis versus Max Pixel of 
Ch2 on the y-axis is generated. Click on the dots and view the images to help you 
draw the region around the cells that are positive for bacteria. 
9. A histogram of the Internalization feature is generated with a region that begins 
at 0, which should be adjusted by observing images. The Internalization feature 
is a ratio of the intensity inside the cell to the intensity of the whole cell. It is 
scaled such that at a value of 0 about half of the intensity is inside. The wizard 
has created a region to designate the inside by making a mask that has used the 
cell image input from step 5 to find the cell surface and eroded this by 4 pixels. 
Note that this mask can be manually adjusted for different cell types when 
necessary. 
10. Create a new histogram with the new Internalization feature based on the eroded 
Object mask. Draw a region to gate on internalized cells by viewing the imagery 
in selected bin mode. 
11. Finally, to eliminate the cells with background labeling and to identify specific 
internalized bacteria, the IDEAS Spot Count feature was used. Spot count is a 
feature that counts the number of connected components or small masks in an 
image. The mask functions, Spot, Peak and Intensity were used to define the 
spots. The spot mask finds the bright details in an image that have a user 
specified radius and threshold above the local background, the mask is refined by 
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breaking apart high intensities into individual spots using the Peak function and 
then spots above an intensity of 200 counts were included. See the Amnis spot-
masking guide for further information. A statistics report template was generated 
by including various features in the Reports menu. 
12. This file was saved as template file to be used for batch analysis of all 
experimental files. 13. In the IDEAS software, click Tools→ Batch Data Files and input all the .rif files. 
Add the compensation matrix file (.ctm) and the template file (.ast) in the 
corresponding sections. Submit the batch for processing. After the processing 
step, all the .rif files are analyzed and .daf files are generated for each of the 
individual raw files. A final report file is generated with statistics for all the 
samples.	  
 
 
 	  	  	  	  	  
 
 
